{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:56:43Z","timestamp":1779217003522,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,4]]},"DOI":"10.7759\/cureus.89350","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:23:32Z","timestamp":1754328212000},"source":"Crossref","is-referenced-by-count":1,"title":["Azithromycin-Induced Stevens-Johnson Syndrome in a Patient With SARS-CoV-2 and End-Stage Renal Disease"],"prefix":"10.7759","author":[{"given":"Jessica R","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir K","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin S","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993, 129:92-6.","journal-title":"Arch Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J Am Acad Dermatol. 2013, 69:173. 10.1016\/j.jaad.2013.05.003","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2016.04.018","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal\u00a0necrolysis in adults 2016","volume":"69","author":"Creamer D","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, et al.. UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal\u00a0necrolysis in adults 2016. J Plast Reconstr Aesthet Surg. 2016, 69:736-41. 10.1016\/j.bjps.2016.04.018","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2020.06.016","article-title":"Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"38","author":"Noe MH","year":"2020","unstructured":"Noe MH, Micheletti RG. Diagnosis and management of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Clin Dermatol. 2020, 38:607-12. 10.1016\/j.clindermatol.2020.06.016","journal-title":"Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2015.10.002","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis - a comprehensive review and guide to therapy. I. Systemic disease","volume":"14","author":"Kohanim S","year":"2016","unstructured":"Kohanim S, Palioura S, Saeed HN, et al.. Stevens-Johnson syndrome\/toxic epidermal necrolysis - a comprehensive review and guide to therapy. I. Systemic disease. Ocul Surf. 2016, 14:2-19. 10.1016\/j.jtos.2015.10.002","journal-title":"Ocul Surf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018, 54:147-76. 10.1007\/s12016-017-8654-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15144","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases","volume":"60","author":"Pej\u010di\u0107 AV","year":"2021","unstructured":"Pej\u010di\u0107 AV. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases. Int J Dermatol. 2021, 60:12-24. 10.1111\/ijd.15144","journal-title":"Int J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas B","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, et al.. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010, 88:60-8. 10.1038\/clpt.2009.252","journal-title":"Clin Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.574425","article-title":"Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19","volume":"12","author":"Venditto VJ","year":"2021","unstructured":"Venditto VJ, Haydar D, Abdel-Latif A, et al.. Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19. Front Immunol. 2021, 12:10.3389\/fimmu.2021.574425","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1136","article-title":"Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"157","author":"Hoffman M","year":"2021","unstructured":"Hoffman M, Chansky PB, Bashyam AR, et al.. Long-term physical and psychological outcomes of Stevens-Johnson syndrome\/toxic epidermal necrolysis. JAMA Dermatol. 2021, 157:712-15. 10.1001\/jamadermatol.2021.1136","journal-title":"JAMA Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.03.032","article-title":"Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"79","author":"Castillo B","year":"2018","unstructured":"Castillo B, Vera N, Ortega-Loayza AG, Seminario-Vidal L. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis. J Am Acad Dermatol. 2018, 79:764-7. 10.1016\/j.jaad.2018.03.032","journal-title":"J Am Acad Dermatol"},{"key":"ref12","unstructured":"ZITHROMAX\u00ae (azithromycin tablets) and (azithromycin for oral suspension). (2009). Accessed. April 12, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/050693s014,050730s021lbl.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00661-0","article-title":"Culprit medications and risk factors associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: population-based nested case-control study","volume":"23","author":"Gronich N","year":"2022","unstructured":"Gronich N, Maman D, Stein N, Saliba W. Culprit medications and risk factors associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: population-based nested case-control study. Am J Clin Dermatol. 2022, 23:257-66. 10.1007\/s40257-021-00661-0","journal-title":"Am J Clin Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2022.12.002","article-title":"Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database","volume":"11","author":"Ubukata N","year":"2023","unstructured":"Ubukata N, Nakatani E, Hashizume H, Sasaki H, Miyachi Y. Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database. JAAD Int. 2023, 11:24-32. 10.1016\/j.jdin.2022.12.002","journal-title":"JAAD Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study","volume":"157","author":"Kridin K","year":"2021","unstructured":"Kridin K, Br\u00fcggen MC, Chua SL, et al.. Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-European multicenter study. JAMA Dermatol. 2021, 157:1182-90. 10.1001\/jamadermatol.2021.3154","journal-title":"JAMA Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.36120","article-title":"Autoimmune and autoinflammatory connective tissue disorders following COVID-19","volume":"6","author":"Lim SH","year":"2023","unstructured":"Lim SH, Ju HJ, Han JH, Lee JH, Lee WS, Bae JM, Lee S. Autoimmune and autoinflammatory connective tissue disorders following COVID-19. JAMA Netw Open. 2023, 6:10.1001\/jamanetworkopen.2023.36120","journal-title":"JAMA Netw Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362355-azithromycin-induced-stevens-johnson-syndrome-in-a-patient-with-sars-cov-2-and-end-stage-renal-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:23:33Z","timestamp":1754328213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362355-azithromycin-induced-stevens-johnson-syndrome-in-a-patient-with-sars-cov-2-and-end-stage-renal-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.89350","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,4]]}}}